July 24, 2026 | 08:49
The University of Hong Kong's Department of Pharmacology and Pharmacy launched Hong Kong's first community pharmacist-led osteoporosis screening programme, deploying the COSA risk assessment tool across community pharmacies to identify undiagnosed patients.